Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00493285 · ClinicalTrials.gov registry record · Phase 1
Safety and Tolerability Study to Evaluate MEDI-534 in Children 6 to < 24 Months of Age
A Phase 1 study, sponsored by MedImmune.
- Completed
- Registry status
- Phase 1
- Development phase
- 49
- Enrollment target
NCT00493285 is a Phase 1 study that has completed, run by MedImmune. The registered enrollment target is 49 participants.
The verdict
NCT00493285, a Phase 1 study, has completed, sponsored by MedImmune.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 49 participants
- Enrollment target
Study Summary
The overall objective of the MEDI-534 clinical development program is to evaluate the safety, efficacy and tolerability of MEDI-534 for the prevention of serious RSV and PIV3 disease in young infants.
Interventions
- BIOLOGICAL MEDI-534
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2007-07 |
| Est. Completion | 2010-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00493285
The ClinicalTrials.gov registry entry for NCT00493285 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MedImmune, which has 210 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MEDI-534 is the first listed.
NCT00493285 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00493285 about?
NCT00493285 is a clinical study titled "Safety and Tolerability Study to Evaluate MEDI-534 in Children 6 to < 24 Months of Age". The overall objective of the MEDI-534 clinical development program is to evaluate the safety, efficacy and tolerability of MEDI-534 for the prevention of serious RSV and PIV3 disease in young infants.
What is the current status of trial NCT00493285?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 49 participants. The study started on 2007-07. Estimated completion is 2010-04.
What interventions are being tested in trial NCT00493285?
The interventions under investigation include: MEDI-534 (BIOLOGICAL).
Who is sponsoring clinical trial NCT00493285?
This trial is sponsored by MedImmune, which has 210 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.